I am a Ph.D. virologist, senior advisor, and health scientist administrator with more than 25
years of experience in basic and applied viral immunology research and in leading and
coordinating global public health and pandemic preparedness programs at the NIH, USG and
global level. I crafted and launched the Centers for Research in Emerging Infectious Diseases
(CREID) in 2020, and the Research and Development of Vaccines and Monoclonal Antibodies for
Pandemic Preparedness (ReVAMPP) in 2024. Both networks were critical to NIAID’s vision for
pandemic preparedness. Additionally, I served as Virology Branch point of contact with other
funders and collaborators such as the WHO, Wellcome Trust, Gates Foundation, CEPI, DoD,
BARDA, etc. on this topic. 

As a NIAID Branch Chief, Senior Advisor to the Director of the Office of AIDS Research (OAR) in
the NIH OD, and as an HIV vaccine investigator at NCI, I made it a priority to teach and mentor
the next generation of scientists and administrators. Regardless of the context/role, promoting
junior investigators has been an overarching goal of mine and something I considered to be an
integral part of my job. I endeavor to continue serving in this role at the CGH.

The Senior Investigator designation provides an important platform to formalize this
engagement, enabling me to contribute to education, research development, joint publications,
and proposal submissions. I view this as a strategic partnership that aligns well with the
Anschutz Medical Campus's values of innovation, interdisciplinary collaboration, and
community impact. I am particularly enthusiastic about mentoring learners and supporting CGH
in building resilient academic-public health capacities in project management across regions
and institutions. 

I am a Ph.D. virologist, senior advisor, and health scientist administrator with more than 25
years of experience in basic and applied viral immunology research and in leading and
coordinating global public health and pandemic preparedness programs at the NIH, USG and
global level. I crafted and launched the Centers for Research in Emerging Infectious Diseases
(CREID) in 2020, and the Research and Development of Vaccines and Monoclonal Antibodies for
Pandemic Preparedness (ReVAMPP) in 2024. Both networks were critical to NIAID’s vision for
pandemic preparedness. Additionally, I served as Virology Branch point of contact with other
funders and collaborators such as the WHO, Wellcome Trust, Gates Foundation, CEPI, DoD,
BARDA, etc. on this topic. 

As a NIAID Branch Chief, Senior Advisor to the Director of the Office of AIDS Research (OAR) in
the NIH OD, and as an HIV vaccine investigator at NCI, I made it a priority to teach and mentor
the next generation of scientists and administrators. Regardless of the context/role, promoting
junior investigators has been an overarching goal of mine and something I considered to be an
integral part of my job. I endeavor to continue serving in this role at the CGH.

The Senior Investigator designation provides an important platform to formalize this
engagement, enabling me to contribute to education, research development, joint publications,
and proposal submissions. I view this as a strategic partnership that aligns well with the
Anschutz Medical Campus's values of innovation, interdisciplinary collaboration, and
community impact. I am particularly enthusiastic about mentoring learners and supporting CGH
in building resilient academic-public health capacities in project management across regions
and institutions. 

I am a Ph.D. virologist, senior advisor, and health scientist administrator with more than 25
years of experience in basic and applied viral immunology research and in leading and
coordinating global public health and pandemic preparedness programs at the NIH, USG and
global level. I crafted and launched the Centers for Research in Emerging Infectious Diseases
(CREID) in 2020, and the Research and Development of Vaccines and Monoclonal Antibodies for
Pandemic Preparedness (ReVAMPP) in 2024. Both networks were critical to NIAID’s vision for
pandemic preparedness. Additionally, I served as Virology Branch point of contact with other
funders and collaborators such as the WHO, Wellcome Trust, Gates Foundation, CEPI, DoD,
BARDA, etc. on this topic. 

As a NIAID Branch Chief, Senior Advisor to the Director of the Office of AIDS Research (OAR) in
the NIH OD, and as an HIV vaccine investigator at NCI, I made it a priority to teach and mentor
the next generation of scientists and administrators. Regardless of the context/role, promoting
junior investigators has been an overarching goal of mine and something I considered to be an
integral part of my job. I endeavor to continue serving in this role at the CGH.

The Senior Investigator designation provides an important platform to formalize this
engagement, enabling me to contribute to education, research development, joint publications,
and proposal submissions. I view this as a strategic partnership that aligns well with the
Anschutz Medical Campus's values of innovation, interdisciplinary collaboration, and
community impact. I am particularly enthusiastic about mentoring learners and supporting CGH
in building resilient academic-public health capacities in project management across regions
and institutions.